Joe Tippens was given months to live. But after taking an anti-parasitic drug, PET scans revealed no detectable cancer cells.
He was cured.
Diagnosed in 2016 with terminal small-cell lung cancer and told he had only months to live, Tippens began taking fenbendazole—a drug commonly used to deworm dogs—alongside supplements like Theracurmin (a turmeric extract) and CBD oil.
Within three months, his scans showed no detectable cancer. Although his remission cannot be definitively attributed to this unconventional regimen, Tippens’s story quickly spread across online communities, igniting curiosity among both patients and practitioners.
Anecdotal reports and early preclinical research now suggest that drugs like fenbendazole, mebendazole, and ivermectin may interfere with cancer cell functions such as energy metabolism, cell division, and survival signaling.
These drugs, part of a class known as benzimidazoles, are inexpensive and widely available, further fueling their appeal. Some integrative oncologists have begun to explore these treatments with select patients, noting cases of unexpected remission. However, none of these antiparasitic drugs are FDA-approved for cancer treatment, and comprehensive clinical trials are lacking. While the stories are compelling and the science promising, experts warn that patients should consult their medical teams before experimenting with unproven protocols.
Source: https://ar.iiarjournals.org/content/44/9/3725